Lilly Likes Concept Of Low-Cost Brand Alternatives As ‘Glide Path’ To No Rebates

Approach could be useful for quickly lowering the cost of insulins, Express Scripts’ Miller points out.

PS1808_Glider_39198733_1200.jpg

More from Pricing Debate

More from Market Access